Protagonist Therapeutics, Takeda Pharmaceutical Announce Positive Phase 3 Rusfertide Results for Polycythemia Vera
Protagonist Therapeutics Inc. (NASDAQ:PTGX) is one of the best mid cap growth stocks to invest in now.
Takeda Pharmaceutical Co Ltd (TAK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Adage Capital Management Phill Gross And Robert Atchinson | 3,433,023 | $51,049,052 | 0.09% | |
| 2. | Renaissance Technologies Jim Simons | 3,157,700 | $46,954,999 | +3% | 0.07% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,400,456 | $20,824,781 | -67% | 0.02% |
| 4. | Quantinno Capital Hoon Kim | 516,044 | $7,673,589 | +8% | 0.05% |
| 5. | Millennium Management Israel Englander | 246,657 | $3,667,790 | -88% | 0% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 67,649 | $1,037,729 | 0% | |
| 2. | 44,519 | $688,264 | 0.13% | |
| 3. | 31,267 | $483,388 | 0.05% | |
| 4. | 24,996 | $386,438 | 0.06% | |
| 5. | 24,338 | $376,269 | 0.01% |
News See All
Takeda Reports Adcetris Combo Approved by EC for Hodgkin Lymphoma
Takeda Pharmaceutical Company Limited (NYSE:TAK)'s ADCETRIS® (brentuximab vedotin) in combination with ECADD was authorized by the European Commission on June 3, 2025, for newly diagnosed adult patients...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2024 Earnings Call Transcript
Christopher O’Reilly: Thank you very much for taking time out of their busy schedule to join our earnings announcement for FY '24 for Takeda. I'm the master of ceremony, Head of IR.
12 Best Low Price Pharma Stocks To Invest In Right Now
Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...
12 Best Japanese Stocks To Buy in 2025
As the dangers of natural disasters increase and the expenses of social security continue to rise, the International Monetary Fund says Japan has to take quick action to strengthen its fiscal situation...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025 Earnings Call Transcript
Christopher O’Reilly: [Foreign Language] Let me start, I’d like to remind everyone that we’ll be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform...
12 Most Profitable Pharmaceutical Stocks Right Now
Healthcare, which includes numerous businesses that offer patient care, conduct research and development of novel treatments, and design, produce, and distribute diagnostic tools and tests, takes the ...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2025 Earnings Call Transcript
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q2 2025 Earnings Call Transcript October 31, 2024Takeda Pharmaceutical Company Limited beats earnings expectations.
10 Best Japanese Stocks To Buy Now
As we navigate through 2024, Japan’s economic landscape is emerging as a compelling arena for investors. Despite facing a rough start to the year, the nation is showing signs of a promising rebound.
10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers
The pharmaceutical industry is one of the most interesting sectors to invest in.
Billionaire Hedge Funds
